Nuzenio

Enrollment Of Phase

Enrollment Of Phase news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Vaxcyte (PCVX) Is Up 8.9% After Completing VAX-31 Phase 3 Enrollment Amid Rising Losses – Has The Bull Case Changed? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 13:32:26 GMTVTVT: Phase 3 CATT1 trial nears enrollment completion as net loss widens on higher R&D spend - TradingViewTradingView · Thu, 06 Aug 2026 20:30:50 GMTTECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingViewTradingView · Thu, 06 Aug 2026 20:27:41 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila TimesThe Manila Times · Thu, 06 Aug 2026 11:56:14 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - Quiver QuantitativeQuiver Quantitative · Thu, 06 Aug 2026 11:44:00 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm InternationalBioPharm International · Wed, 05 Aug 2026 19:39:16 GMTEyePoint Completes Enrollment in Two Phase 3 Trials Evaluating Duravyu for DME - Eyewire+Eyewire+ · Wed, 05 Aug 2026 18:46:05 GMTKYMR: KT-621 Phase 2b AD trial enrollment finished early; $65M Q2 revenue and $1.5B cash runway - TradingViewTradingView · Wed, 05 Aug 2026 11:16:20 GMT

Timeline

Fri, 07 Aug 2026 13:32:26 GMTVaxcyte (PCVX) Is Up 8.9% After Completing VAX-31 Phase 3 Enrollment Amid Rising Losses – Has The Bull Case Changed? - simplywall.st
Thu, 06 Aug 2026 20:30:50 GMTVTVT: Phase 3 CATT1 trial nears enrollment completion as net loss widens on higher R&D spend - TradingView
Thu, 06 Aug 2026 20:27:41 GMTTECX: TX45 Phase 2 trial enrollment completed; topline results expected Q1 2027 - TradingView
Thu, 06 Aug 2026 11:56:14 GMTRactigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS - The Manila Times
Thu, 06 Aug 2026 11:44:00 GMTLexicon Pharmaceuticals Reports Q2 2026 Results; Completes Enrollment in Phase 3 SONATA-HCM Study and Advances ZYNQUISTA NDA Resubmission - Quiver Quantitative
Wed, 05 Aug 2026 19:39:16 GMTOpus Genetics Completes Phase 3 Enrollment for AAV Gene Therapy OPGx-LCA5 - BioPharm International

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Enrollment Of Phase.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.